Clinical trial

Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis

NCT01892722

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Interferon beta-1a Normalized identity: interferon beta-1aView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Fingolimod Normalized identity: fingolimodView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo capsule Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo i.m. injection Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2013-07-26

PhasePHASE3

Conditions

Multiple Sclerosisverified · MONDO: multiple sclerosis

Interventions

Interferon beta-1aDRUG · verified · RxNorm: interferon beta-1a

FingolimodDRUG · verified · RxNorm: fingolimod

Placebo capsuleDRUG

Placebo i.m. injectionDRUG

Sponsors & collaborators

Novartis Pharmaceuticalslead sponsor

Mapped research locations

LondonUnited Kingdom2 MoscowRussia2 BostonMassachusetts, United States1 Los AngelesCalifornia, United States1 PhiladelphiaPennsylvania, United States1 MiamiFlorida, United States1 San FranciscoCalifornia, United States1 MadridSpain1 BirminghamAlabama, United States1 DetroitMichigan, United States1 Salt Lake CityUtah, United States1 Saint PetersburgRussia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01892722 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.